Development of an ocular delivery system for controlled release of cannabinoids

This project aims toward development of a polymeric delivery system for controlled release of cannabinoids, with application in treatment of patients suffering from glaucoma. InMed Pharmaceuticals is a clinical stage biopharmaceutical company that specializes in developing cannabis based therapies with innovative drug delivery systems. So far, two candidates were introduced: CTI-085 is a topical formulation for the treatment of glaucoma; and CT1-091 for arthritic joint pain and swelling. . The main focus of this project is formulation design and development. A thorough biophysical characterization and data analysis will be performed with the purpose of optimizing the manufacturing process as well as the delivery system. The proposed work will serve as a solid platform for future clinical studies on novel cannabinoid-based treatments developed at InMed Pharmaceuticals.

Faculty Supervisor:

Vikramaditya Yadav

Student:

Maryam Kabiri

Partner:

InMed Pharmaceuticals Inc.

Discipline:

Engineering - chemical / biological

Sector:

Life sciences

University:

University of British Columbia